Advertisement
Screener

LogicMark, Inc. (LGMK) Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation

LogicMark, Inc. Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation

LogicMark, Inc. (LGMK) reported Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation of $14.02 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.

Discontinued › Notes › Compensation Related Costs

us-gaap:AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation · last filed 2021-11-15

  • LogicMark, Inc. adjustments to additional paid in capital, income tax deficiency from share-based compensation for the quarter ending 2021-09-30 was $12.79M.
  • LogicMark, Inc. adjustments to additional paid in capital, income tax deficiency from share-based compensation for the quarter ending 2021-06-30 was -$2.69M.
  • LogicMark, Inc. adjustments to additional paid in capital, income tax deficiency from share-based compensation for the quarter ending 2021-03-31 was $3.92M.
  • LogicMark, Inc. adjustments to additional paid in capital, income tax deficiency from share-based compensation for the quarter ending 2020-12-31 was -$1.56M.
  • LogicMark, Inc. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2020 was $578.80K, a 74.93% decline from fiscal 2019.
  • LogicMark, Inc. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2019 was $2.31M.
Period endAdjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 3 monthAdjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 6 monthAdjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 9 monthAdjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 12 month
2021-09-30$12.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$10.10M
derived: sum of 2 quarters · filed 2021-11-15
$14.02M
10-Q · filed 2021-11-15
$12.46M
derived: sum of 4 quarters · filed 2021-11-15
2021-06-30-$2.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$1.23M
10-Q · filed 2021-08-16
-$328.27K
derived: sum of 3 quarters · filed 2021-08-16
2021-03-31$3.92M
10-Q · filed 2021-05-17
$2.36M
derived: sum of 2 quarters · filed 2021-05-17
2020-12-31-$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15
$578.80K
10-K · filed 2021-04-15
2020-09-30$2.14M
10-Q · filed 2020-11-16
2019-12-31$2.31M
10-K · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bone Biologics Corp (BBLG)United States$0.001B
ENvue Medical, Inc. (FEED)United States$0.011B
Lifeward Ltd. (LFWD)$0.021B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
MYOMO, INC. (MYO)United States$0.065B-2.85
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B